Rexahn Pharmaceuticals, Inc.  

(Public, NYSEMKT:RNN)   Watch this stock  
Find more results for NYSEAMEX:RNN
1.04
0.00 (0.00%)
After Hours: 1.03 -0.01 (-0.96%)
Apr 23, 6:50PM EDT  
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 1.01 - 1.08
52 week 0.30 - 1.85
Open 1.04
Vol / Avg. 0.00/5.75M
Mkt cap 183.71M
P/E     -
Div/yield     -
EPS -0.07
Shares 176.64M
Beta 1.21
Inst. own 7%
Feb 10, 2014
REXAHN PHARMACEUTICALS INC at Biotechnology Industry Organization CEO & Investor Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -61.23% -55.11%
Return on average equity -97.07% -85.74%
Employees 14 -
CDP Score - -

Address

Suite 455, 15245 Shady Grove Road
ROCKVILLE, MD 20850
United States - Map
+1-240-2685300 (Phone)
+1-240-2685310 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Rexahn Pharmaceuticals, Inc. (Rexahn) is a development-stage biopharmaceutical company. The Company focuses on the development of cures for cancer to patients worldwide. The Company�s pipeline features one drug candidate in Phase II clinical trials. The Company also has several other drug candidates in pre-clinical development. In addition, the Company has two renal cell carcinoma (CNS) candidates, Serdaxin, CNS Disorders drug for depression and neurodegenerative diseases and Zoraxel, which is a erectile dysfunction (ED) and sexual dysfunction drug that are in clinical stages and the Company is are exploring options for further development . The Company�s drug candidate, Archexin is an anticancer Akt inhibitor.

Officers and directors

Chang H. Ahn Chairman of the Board, Chief Scientist
Age: 61
Bio & Compensation  - Reuters
Rakesh Soni President, Chief Operating Officer
Age: 57
Bio & Compensation  - Reuters
Peter D. Suzdak Ph.D. Chief Executive Officer
Age: 54
Bio & Compensation  - Reuters
Tae Heum Jeong Chief Financial Officer, Secretary
Bio & Compensation  - Reuters
Mark P. Carthy Director
Bio & Compensation  - Reuters
Charles G Beever Independent Director
Age: 60
Bio & Compensation  - Reuters
Peter C. Brandt Independent Director
Age: 56
Bio & Compensation  - Reuters
Kwang Soo Soo Cheong Independent Director
Age: 52
Bio & Compensation  - Reuters
Si Moon Hwang Independent Director
Age: 44
Bio & Compensation  - Reuters